DESIGN THERAPEUTICS INC (DSGN)

US25056L1035 - Common Stock

4.4  -0.1 (-2.22%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

2023
(2023-12-31)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
Revenue
0.000.000.00230.00K830.00K
Operating Expenses
78.19M67.59M35.83M8.56M2.74M
Research and Development
57.06M48.61M24.78M6.06M1.65M
Selling, General, and Administrative Expenses
21.13M18.98M11.05M2.50M1.09M
Operating Income
-78.19M-67.59M-35.83M-8.33M-1.91M
Other Income/Expense
11.33M4.29M300.00K50.00K-140.00K
Income Before Taxes
-66.86M-63.31M-35.53M-8.28M-2.05M
Net Income
-66.86M-63.31M-35.53M-8.28M-2.05M
EBITDA
-77.65M-67.18M-35.70M-8.32MN/A
 
Per Share Data
EPS Diluted Total Ops
-1.19-1.14-0.77-0.15-0.04
Non GAAP EPS
-1.20-1.14-0.86N/AN/A
 
Statistics
Profit Margin
N/AN/AN/A-3600.00%-246.99%
Operating Profit Margin
N/AN/AN/A-3621.74%-230.12%

All data in USD

Charts